Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Endothelial TDP-43 controls sprouting angiogenesis and vascular barrier integrity, and its deletion triggers neuroinflammation
Víctor Arribas, … , Bettina Schmid, Eloi Montanez
Víctor Arribas, … , Bettina Schmid, Eloi Montanez
Published February 1, 2024
Citation Information: JCI Insight. 2024;9(5):e177819. https://doi.org/10.1172/jci.insight.177819.
View: Text | PDF
Research Article Angiogenesis Vascular biology

Endothelial TDP-43 controls sprouting angiogenesis and vascular barrier integrity, and its deletion triggers neuroinflammation

  • Text
  • PDF
Abstract

TAR DNA-binding protein 43 (TDP-43) is a DNA/RNA-binding protein that regulates gene expression, and its malfunction in neurons has been causally associated with multiple neurodegenerative disorders. Although progress has been made in understanding the functions of TDP-43 in neurons, little is known about its roles in endothelial cells (ECs), angiogenesis, and vascular function. Using inducible EC-specific TDP-43–KO mice, we showed that TDP-43 is required for sprouting angiogenesis, vascular barrier integrity, and blood vessel stability. Postnatal EC-specific deletion of TDP-43 led to retinal hypovascularization due to defects in vessel sprouting associated with reduced EC proliferation and migration. In mature blood vessels, loss of TDP-43 disrupted the blood-brain barrier and triggered vascular degeneration. These vascular defects were associated with an inflammatory response in the CNS with activation of microglia and astrocytes. Mechanistically, deletion of TDP-43 disrupted the fibronectin matrix around sprouting vessels and reduced β-catenin signaling in ECs. Together, our results indicate that TDP-43 is essential for the formation of a stable and mature vasculature.

Authors

Víctor Arribas, Yara Onetti, Marina Ramiro-Pareta, Pilar Villacampa, Heike Beck, Mariona Alberola, Anna Esteve-Codina, Angelika Merkel, Markus Sperandio, Ofelia M. Martínez-Estrada, Bettina Schmid, Eloi Montanez

×

Figure 2

TDP-43 is required for FN matrix assembly and cell-matrix adhesion.

Options: View larger image (or click on image) Download as PowerPoint
TDP-43 is required for FN matrix assembly and cell-matrix adhesion.
(A) ...
(A) Confocal high-magnification images of P7 control and TDP-43iΔEC retinas stained for IB4 (green) and fibronectin (FN, red). White rectangles indicate magnified regions. Note the FN fibrils (arrows) associated to control vessels and the presence of irregular FN aggregates (arrowheads) in TDP-43iΔEC vessels. A indicates magnified region of image. Scale bar: 20 μm. (B) Western blot analysis of TDP-43 in total lysates of TDP-43fl/fl and TDP-43fl/fl;Cadh5Cre mouse lungs ECs (mLECs) 48 hours after 4-hydroxytamoxifen (4-OHT) treatment. Tubulin was used as a loading control. B indicates magnified region of image. (C) Confocal high-magnification images of TDP-43fl/fl and TDP-43fl/fl;Cadh5Cre mLECS stained for EC marker VE-cadherin (VEcad, green), FN (red), and Hoechst (nuclei, blue). Note the abnormal FN aggregates (arrowheads) in TDP-43fl/fl;Cadh5Cre mLECs. Scale bar: 10 μm. (D) Confocal high-magnification images of TDP-43fl/fl and TDP-43fl/fl;Cadh5Cre mLECS stained for VEcad (green), the focal adhesion maker Paxillin (Pax, red), and Hoechst (nuclei, blue). Scale bar: 10 μm. (E) Western blot analysis of TDP-43 in total lysates of human umbilical vein ECs (HUVECs) transfected with either control (scramble, Scr) or TDP-43 small interfering RNAs (siRNAs). GAPDH was using as a loading control. Graph shows the quantification of the mean TDP-43 protein expression levels corrected for background and normalized to expression in Scr and TDP-43 siRNA–transfected HUVECs. Data are shown as mean ± SEM. ***P < 0.001. One-way ANOVA. (F) Confocal high-magnification images of control and TDP-43–depleted HUVECs stained for Pax (green), F-actin (red), and TDP-43 (blue). Scale bar: 20 μm. (G) Quantification of the ratio between the longest side and the shortest side (cellular elongation index) of the ECs in control and TDP-43–depleted HUVECs. Data are shown as mean ± SEM. ***P < 0.001. One-way ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts